Table 3. Adherence rates of BCLC treatment guideline in each BCLC stage in the E-Cohort and the L-Cohort.

BCLC stage	E-Cohort (n = 8203)	L-Cohort (n = 4776)
0~A	1552 (35.1%)	1213 (55.0%)	<0.001
B	573 (65.5%)	355 (58.8%)	0.009
C	30 (1.3%)	162 (9.7%)	<0.001
D	133 (21.4%)	145 (47.5%)	<0.001

Abbreviations: BCLC, Barcelona clinic liver cancer